GlassScriptPhysician profile
Wood B Gibbs
NPI 1740405323
$1,565.03
in general payments reported to CMS, 2019-2025
19 companies · $432 in 2025
The $432 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2020: $216 · 2021: $41.50 · 2022: $74.14 · 2023: $232 · 2024: $349 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,013.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,012.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $743.42 | 2019-2025 | |
| Pentax of America, INC. | $183.35 | 2021-2024 | Pentax Medical, Inspira, C2 Cryoballoon |
| Cook Medical LLC | $153.93 | 2023-2025 | Hemospray, Echotip Insight, Echotip |
| Enterra Medical, INC. | $135.80 | 2025 | |
| Boston Scientific Corporation | $81.81 | 2020-2024 | Cre Pro |
| Ambu INC. | $45.79 | 2020 | |
| Pfizer INC. | $25.55 | 2019-2025 | |
| Intercept Pharmaceuticals, INC. | $20.45 | 2020 | |
| Janssen Biotech, INC. | $18.27 | 2019 | |
| Ucb, INC. | $17.64 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.31 | 2020 | |
| Alnylam Pharmaceuticals INC. | $16.33 | 2023 | Givlaari |
| Ardelyx, INC. | $16.28 | 2025 | Ibsrela |
| Takeda Pharmaceuticals U.S.A., INC. | $16.19 | 2019 | |
| Merck Sharp & Dohme LLC | $15.99 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $15.93 | 2024 | Resmetirom |
| Amag Pharmaceuticals, INC. | $14.52 | 2019 | |
| Medtronic, INC. | $13.48 | 2024 | Interstim |
| Allergan, INC. | $12.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wood Gibbs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.